PE-backed StageBio buys TPL Path Labs

StageBio, which is backed by Ampersand Capital Partners, has acquired TPL Path Labs, a German CRO service provider.

21 October 2020•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles